Event

On September 21 and 22, join us for the symposium, Addiction as a chronic illness? Promises and perils of a new drug policy paradigm. Activists and physicians have worked hard to end punitive responses to addiction and recast it as a chronic illness treatable, in part, with medications like buprenorphine. But the “chronic illness” paradigm raises new questions: How to avoid the stigma and social limitations associated with chronic illness? How to prevent pharmaceutical industry influence over medication assisted treatment (MAT)? This symposium brings together leading scholars of addiction, pharmaceuticals, and chronic illness to explore the promises and perils of applying this paradigm to drug dependence and addiction.

The symposium is sponsored by The Baldy Center for Law & Social Policy.

David Herzberg, PhD
Email: herzberg@buffalo.edu
Phone: (716) 645-8416